Index -
P/E -
EPS (ttm) -1.78
Insider Own 1.21%
Shs Outstand 54.60M
Perf Week -7.22%
Market Cap 2.81B
Forward P/E 16.73
EPS next Y 3.06
Insider Trans 0.00%
Shs Float 54.18M
Perf Month -14.13%
Income -97.43M
PEG -
EPS next Q 0.60
Inst Own 105.85%
Short Float 7.69%
Perf Quarter -14.12%
Sales 1.82B
P/S 1.55
EPS this Y 9.20%
Inst Trans -6.05%
Short Ratio 9.00
Perf Half Y 13.86%
Book/sh 60.33
P/B 0.85
EPS next Y 16.90%
ROA -2.11%
Short Interest 4.17M
Perf Year -12.39%
Cash/sh 1.21
P/C 42.43
EPS next 5Y 9.99%
ROE -3.06%
52W Range 43.04 - 66.14
Perf YTD -8.48%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -2.08%
52W High -22.48%
Beta 1.82
Dividend TTM -
Quick Ratio 1.03
Sales past 5Y 1.85%
Gross Margin 50.28%
52W Low 19.12%
ATR (14) 1.60
Dividend Ex-Date -
Current Ratio 2.10
EPS Y/Y TTM -87.48%
Oper. Margin -1.23%
RSI (14) 25.30
Volatility 3.27% 2.67%
Employees 6550
Debt/Eq 0.43
Sales Y/Y TTM 14.02%
Profit Margin -5.36%
Recom 1.27
Target Price 75.11
Option/Short Yes / Yes
LT Debt/Eq 0.41
EPS Q/Q -206.33%
Payout -
Rel Volume 2.47
Prev Close 52.13
Sales Surprise 2.11%
EPS Surprise 3.33%
Sales Q/Q 27.11%
Earnings May 02 BMO
Avg Volume 462.88K
Price 51.27
SMA20 -10.04%
SMA50 -13.71%
SMA200 -7.91%
Trades
Volume 1,145,416
Change -1.65%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-13-24 Initiated
Stephens
Overweight
$72
Jan-22-24 Initiated
UBS
Buy
$75
Jan-03-24 Initiated
William Blair
Outperform
Dec-15-23 Reiterated
Needham
Buy
$62 → $70
Oct-20-23 Initiated
ROTH MKM
Buy
$75
Jun-26-23 Initiated
Needham
Buy
$70
May-12-23 Upgrade
Wells Fargo
Equal Weight → Overweight
$55 → $67
Oct-12-22 Initiated
Jefferies
Buy
$60
Oct-11-22 Initiated
Goldman
Buy
$57
Sep-12-22 Initiated
Evercore ISI
Outperform
$68
Sep-12-22 Initiated
Canaccord Genuity
Buy
$67
Jun-28-22 Initiated
Argus
Hold
Jun-27-22 Resumed
Loop Capital
Buy
$68
Jun-16-22 Initiated
Wells Fargo
Equal Weight
$61
Show Previous Ratings
May-03-24 11:22AM
03:04AM
May-02-24 11:48AM
10:56AM
07:55AM
07:10AM
Loading…
07:10AM
06:11AM
(Associated Press Finance)
06:00AM
Apr-25-24 11:34AM
Apr-17-24 07:00AM
Apr-16-24 08:00AM
Mar-28-24 07:00AM
Feb-23-24 10:20AM
Feb-22-24 11:06PM
(Thomson Reuters StreetEvents) +5.86%
06:31AM
06:23AM
Loading…
06:23AM
(Associated Press Finance)
06:00AM
Feb-12-24 11:30AM
Feb-07-24 04:15PM
Jan-29-24 08:00AM
Jan-26-24 06:00AM
Jan-25-24 08:30AM
Jan-04-24 10:53AM
Jan-03-24 06:00AM
Dec-28-23 05:00AM
Dec-05-23 06:00AM
Nov-29-23 09:55AM
Nov-16-23 04:15PM
Nov-13-23 09:55AM
Nov-08-23 08:42PM
08:43AM
Loading…
08:43AM
01:16AM
Nov-07-23 09:51PM
(Thomson Reuters StreetEvents)
07:15AM
06:50AM
06:12AM
(Associated Press Finance)
06:00AM
Oct-31-23 10:01AM
Oct-30-23 08:00AM
Oct-25-23 12:10PM
Oct-20-23 06:00AM
Oct-19-23 06:58AM
06:51AM
Oct-16-23 07:00AM
Sep-29-23 11:34AM
Sep-25-23 06:35AM
06:00AM
05:00AM
Sep-18-23 08:30AM
Sep-07-23 08:40AM
Aug-08-23 08:24AM
Aug-03-23 10:43AM
07:25AM
06:21AM
06:00AM
Jul-21-23 04:34AM
Jul-11-23 04:45PM
Jul-10-23 07:28AM
Jul-06-23 08:30AM
Jul-03-23 04:27AM
Jun-28-23 04:30PM
Jun-14-23 07:21AM
07:06AM
Jun-02-23 04:01PM
May-22-23 08:47AM
May-04-23 07:25AM
06:20AM
06:00AM
May-01-23 05:45PM
Apr-27-23 08:35AM
Apr-13-23 12:21PM
Apr-03-23 07:00AM
Mar-16-23 07:13AM
06:58AM
Mar-15-23 04:30PM
Mar-03-23 10:35AM
Feb-27-23 08:00AM
Feb-24-23 05:20AM
Feb-23-23 06:00AM
Feb-10-23 03:45PM
Feb-08-23 06:00AM
Jan-17-23 09:00AM
Jan-14-23 03:14PM
Jan-12-23 06:08AM
Jan-05-23 03:10PM
Dec-28-22 07:23AM
07:08AM
Dec-12-22 09:03AM
Dec-01-22 09:00AM
Nov-17-22 10:05AM
08:00AM
Nov-11-22 05:39AM
Nov-10-22 10:30AM
Nov-02-22 07:25AM
06:00AM
Oct-28-22 03:58PM
Oct-27-22 10:03AM
Oct-26-22 12:10PM
10:02AM
Oct-13-22 09:30AM
Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
KLECKNER JOHN Principal Accounting Officer Aug 07 '23 Sale 59.18 174 10,297 4,218 Aug 07 08:00 PM KLECKNER JOHN Principal Accounting Officer Jul 20 '23 Sale 65.32 67 4,376 4,392 Jul 20 08:00 PM BERRY PHILLIP BENJAMIN (BEN) SVP, Chief Financial Officer Jun 02 '23 Sale 54.17 645 34,940 20,223 Jun 02 08:00 PM Vinnakota Rajiv Director May 08 '23 Option Exercise 42.43 1,396 59,232 13,297 May 09 08:00 PM Vinnakota Rajiv Director May 08 '23 Sale 57.18 1,396 79,823 11,901 May 09 08:00 PM
Index -
P/E 31.50
EPS (ttm) 4.66
Insider Own 0.70%
Shs Outstand 65.90M
Perf Week 2.43%
Market Cap 9.73B
Forward P/E 25.08
EPS next Y 5.85
Insider Trans -9.33%
Shs Float 65.77M
Perf Month 3.57%
Income 312.83M
PEG 4.50
EPS next Q 1.36
Inst Own 91.30%
Short Float 0.50%
Perf Quarter 12.84%
Sales 3.54B
P/S 2.75
EPS this Y 11.63%
Inst Trans 0.89%
Short Ratio 1.00
Perf Half Y 19.43%
Book/sh 35.48
P/B 4.14
EPS next Y 9.71%
ROA 7.16%
Short Interest 0.33M
Perf Year 22.44%
Cash/sh 3.03
P/C 48.38
EPS next 5Y 7.00%
ROE 14.02%
52W Range 111.62 - 148.51
Perf YTD 18.76%
Dividend Est. 1.80 (1.23%)
P/FCF 37.55
EPS past 5Y 7.22%
ROI 10.18%
52W High -1.14%
Beta 0.60
Dividend TTM 2.02 (1.38%)
Quick Ratio 0.89
Sales past 5Y 4.79%
Gross Margin 29.35%
52W Low 31.52%
ATR (14) 2.39
Dividend Ex-Date Apr 24, 2024
Current Ratio 1.30
EPS Y/Y TTM 34.19%
Oper. Margin 13.64%
RSI (14) 68.52
Volatility 1.67% 1.53%
Employees 13800
Debt/Eq 0.49
Sales Y/Y TTM 6.16%
Profit Margin 8.83%
Recom 2.12
Target Price 159.00
Option/Short Yes / Yes
LT Debt/Eq 0.31
EPS Q/Q 50.18%
Payout 37.20%
Rel Volume 0.81
Prev Close 145.92
Sales Surprise 2.82%
EPS Surprise 9.95%
Sales Q/Q 6.44%
Earnings Apr 25 AMC
Avg Volume 330.13K
Price 146.81
SMA20 4.20%
SMA50 3.83%
SMA200 12.86%
Trades
Volume 267,951
Change 0.61%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-29-24 Upgrade
William Blair
Mkt Perform → Outperform
Jan-03-24 Upgrade
Robert W. Baird
Neutral → Outperform
$125 → $150
Aug-02-21 Downgrade
William Blair
Outperform → Mkt Perform
Apr-14-21 Downgrade
Robert W. Baird
Outperform → Neutral
$150
Oct-14-20 Initiated
Seaport Global Securities
Neutral
Apr-27-20 Upgrade
BofA/Merrill
Neutral → Buy
$101 → $131
Mar-25-20 Upgrade
BMO Capital Markets
Market Perform → Outperform
$105
Mar-04-20 Upgrade
Wells Fargo
Equal Weight → Overweight
$110 → $122
Feb-26-20 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$136 → $116
Jul-08-19 Initiated
Morgan Stanley
Overweight
$144
Apr-05-19 Reiterated
BofA/Merrill
Underperform
$87 → $100
Feb-27-19 Upgrade
Robert W. Baird
Neutral → Outperform
$115
May-18-18 Initiated
Jefferies
Hold
Dec-07-16 Downgrade
BofA/Merrill
Buy → Underperform
Oct-13-16 Initiated
Jefferies
Hold
$83
Jan-05-16 Downgrade
Robert W. Baird
Outperform → Neutral
$80
Nov-02-15 Upgrade
Deutsche Bank
Hold → Buy
$72 → $84
Sep-15-15 Upgrade
BofA/Merrill
Neutral → Buy
May-01-15 Upgrade
BofA/Merrill
Underperform → Neutral
Feb-19-13 Reiterated
Deutsche Bank
Hold
$53 → $56
Show Previous Ratings
May-02-24 02:21AM
May-01-24 12:00PM
Apr-30-24 12:09PM
09:50AM
09:38AM
01:34PM
Loading…
Apr-29-24 01:34PM
10:26AM
07:10AM
Apr-27-24 03:05AM
Apr-25-24 09:53PM
06:51PM
06:20PM
05:58PM
05:18PM
(Associated Press Finance)
05:00PM
09:40AM
Loading…
09:40AM
Apr-24-24 08:36AM
Apr-23-24 07:04AM
Apr-19-24 09:40AM
Apr-18-24 10:01AM
Apr-11-24 05:00PM
Apr-10-24 12:10PM
Apr-09-24 09:40AM
Apr-03-24 09:40AM
Apr-02-24 09:50AM
Mar-28-24 09:15AM
Mar-25-24 09:45AM
Mar-22-24 09:40AM
Mar-20-24 05:00PM
Mar-18-24 09:40AM
05:00PM
Loading…
Mar-12-24 05:00PM
Mar-06-24 09:15AM
Mar-01-24 09:45AM
Feb-29-24 05:00PM
Feb-28-24 09:40AM
Feb-19-24 09:40AM
Feb-13-24 01:42PM
08:21AM
Feb-12-24 12:03PM
09:50AM
09:40AM
09:15AM
Feb-09-24 05:01PM
(Morningstar Research) +5.18%
11:42AM
10:00AM
Feb-08-24 05:35PM
05:15PM
(Associated Press Finance)
05:00PM
Feb-01-24 10:00AM
Jan-30-24 05:11AM
Jan-23-24 05:00PM
Jan-18-24 05:00PM
Jan-11-24 09:40AM
Jan-04-24 05:00PM
Jan-02-24 05:00PM
Dec-08-23 01:05AM
Dec-04-23 08:30AM
Nov-28-23 09:40AM
Nov-25-23 03:03AM
Nov-24-23 11:31AM
Nov-08-23 09:40AM
Nov-02-23 09:40AM
Nov-01-23 05:00PM
Oct-31-23 10:32AM
Oct-27-23 01:00PM
Oct-26-23 04:28PM
Oct-25-23 06:50PM
06:47PM
05:50PM
(Associated Press Finance)
05:00PM
Oct-24-23 07:08AM
Oct-23-23 10:00AM
Oct-18-23 05:00PM
11:40AM
10:01AM
Oct-17-23 12:10PM
09:50AM
Oct-13-23 09:40AM
Oct-12-23 05:00PM
Oct-02-23 10:41AM
06:07AM
Sep-29-23 10:31AM
Sep-28-23 09:40AM
Sep-27-23 09:40AM
Sep-19-23 09:50AM
Sep-18-23 06:48AM
Sep-15-23 11:13AM
Sep-13-23 11:20AM
Sep-11-23 12:00PM
10:00AM
09:40AM
07:24AM
Sep-08-23 11:30AM
Sep-07-23 11:30AM
Sep-05-23 05:00PM
Sep-04-23 09:40AM
Sep-01-23 09:15AM
Aug-30-23 12:12PM
Aug-25-23 12:20PM
Aug-24-23 09:40AM
AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. It operates through the following segments: Pharma, Beauty and Home, and Food and Beverage. The company was founded in 1940 and is headquartered in Crystal Lake, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Tlili Hedi Segment President May 01 '24 Option Exercise 74.79 3,167 236,860 12,546 May 01 05:52 PM Tlili Hedi Segment President May 01 '24 Sale 145.09 4,634 672,344 9,379 May 01 05:52 PM Kampouri Monnas Giovanna Director Mar 12 '24 Sale 142.45 2,000 284,906 9,648 Mar 12 02:05 PM Touya Gael Segment President Mar 11 '24 Sale 142.84 3,500 499,932 33,426 Mar 12 01:55 PM Tanda Stephan B. President and CEO Mar 04 '24 Option Exercise 74.79 32,000 2,393,280 191,024 Mar 05 02:39 PM Tanda Stephan B. President and CEO Mar 04 '24 Sale 141.67 32,000 4,533,394 159,024 Mar 05 02:39 PM Prieur Marc Segment President Dec 07 '23 Sale 126.24 3,200 403,968 13,828 Dec 07 04:19 PM Kampouri Monnas Giovanna Director Nov 24 '23 Sale 128.38 2,387 306,447 11,648 Nov 24 06:13 PM FOTIADES GEORGE L Director Aug 28 '23 Option Exercise 66.59 9,500 632,605 14,462 Aug 29 05:04 PM FOTIADES GEORGE L Director Aug 28 '23 Sale 128.46 9,500 1,220,333 4,962 Aug 29 05:04 PM Tlili Hedi Segment President Aug 24 '23 Sale 125.23 2,989 374,304 9,379 Aug 25 01:57 PM FOTIADES GEORGE L Director Aug 10 '23 Sale 122.01 7,940 968,760 4,962 Aug 10 06:15 PM Chainey Kimberly EVP and Chief Legal Officer Aug 10 '23 Sale 122.84 1,420 174,438 7,199 Aug 10 06:43 PM Gong Xiangwei President, Asia Aug 09 '23 Sale 123.13 3,000 369,399 17,859 Aug 10 12:15 PM Prieur Marc Segment President Aug 07 '23 Sale 121.00 8,000 968,000 17,028 Aug 08 03:52 PM Vinczeller Shiela Chief Human Resources Officer Aug 02 '23 Sale 121.08 2,000 242,168 20,467 Aug 03 12:18 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite